Universität Wien

301407 VO DNA-Tumor Viruses, from Cancer Agent to therapy (2022W)

Elective Course in Molecular Medicine

2.00 ECTS (1.00 SWS), SPL 30 - Biologie
ON-SITE
Moodle

Registration/Deregistration

Note: The time of your registration within the registration period has no effect on the allocation of places (no first come, first served).
Register/Deregister for this course

Details

Language: English

Examination dates

Tuesday 20.12.2022 Tuesday 24.01.2023 11:00 - 12:00 BZB/Seminarraum 1/2, 6.Ebene 6.501/6.504, Dr.-Bohr-Gasse 9, 1030 Wien Wednesday 08.03.2023 11:00 - 12:00 BZB/Seminarraum 1/2, 6.Ebene 6.501/6.504, Dr.-Bohr-Gasse 9, 1030 Wien Tuesday 13.06.2023

Lecturers

Classes (iCal) - next class is marked with N

Termine: 15., 21., 22., 24., 28. und 29.11. 2022
jeweils von 14-16 Uhr im SR 1/BZB, Dr.Bohrgasse 9/6.Stock, 1030 Wien

Tuesday 15.11. 14:00 - 16:00 BZB/Seminarraum 1/2, 6.Ebene 6.501/6.504, Dr.-Bohr-Gasse 9, 1030 Wien
Monday 21.11. 14:00 - 16:00 BZB/Seminarraum 1/2, 6.Ebene 6.501/6.504, Dr.-Bohr-Gasse 9, 1030 Wien
Tuesday 22.11. 14:00 - 16:00 BZB/Seminarraum 1/2, 6.Ebene 6.501/6.504, Dr.-Bohr-Gasse 9, 1030 Wien
Thursday 24.11. 14:00 - 16:00 BZB/Seminarraum 1/2, 6.Ebene 6.501/6.504, Dr.-Bohr-Gasse 9, 1030 Wien
Monday 28.11. 14:00 - 16:00 BZB/Seminarraum 1/2, 6.Ebene 6.501/6.504, Dr.-Bohr-Gasse 9, 1030 Wien
Tuesday 29.11. 14:00 - 16:00 BZB/Seminarraum 1/2, 6.Ebene 6.501/6.504, Dr.-Bohr-Gasse 9, 1030 Wien

Information

Aims, contents and method of the course

DNA tumour viruses play not only an import role as human pathogens causing diseases like cervical cancer but also serve as important tools to elucidate basic mechanisms of cancerogenesis. For example, the tumour suppressor protein p53 was discovered as a cellular protein of 53kDa targeted and inactivated by the large tumour antigen (LT) of the DNA tumour virus SV40. More recently, a novel anti-cancer strategy was developed based on the lytic function of DNA tumour viruses (e.g. ONYX015).
The lecture will include the following topics:
Classification of DNA tumour viruses
Lytic and transformation cycle
Viral oncoproteins and their cellular targets: p53, pRB (the retinoblastoma gene product), protein phosphatase 2A (PP2A) and others
Human Papillomavirus and the development of cervical carcinoma
Cancer therapy with adenovirus mutants

Assessment and permitted materials

Written exam

Minimum requirements and assessment criteria

Maximum points: 40. Usually 4 questions, 10 points/question
Grading key: <20= 5 (insufficient); 20-24 = 4 (sufficient); 25-29 = 3 (satisfactory); 30-34 = 2 (good); 35-40 = 1 (very good)

Examination topics

Content of the course. Lectures in English, exam in English. Questions can also be answered in German

Reading list

Course documents in Moodle. Information on the literature available on the slides in Moodle.

Association in the course directory

MMB IV-2, MMB IV-3, MMB W-2, MMEI III, UF MA BU 01, UF MA BU 04

Last modified: We 26.04.2023 09:28